Similar articles

• High prevalence of bcl-2 oncoprotein expression in small cell lung cancer.

  Higashiyama M, Doi O, Kodama K, Yokouchi H, Tateishi R. Higashiyama M, et al. Anticancer Res. 1995 Mar-Apr;15(2):503-5. Anticancer Res. 1995. PMID: 7763030
• Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions.

  Kim CY, Tsai MH, Osmanian C, Graeber TG, Lee JE, Giffard RG, DiPaolo JA, Peehl DM, Giaccia AJ. Kim CY, et al. Cancer Res. 1997 Oct 1;57(19):4200-4. Cancer Res. 1997. PMID: 9331075
• Use of monoclonal antibodies as probes for oncogene products.

  Niman HL. Niman HL. Immunol Ser. 1990;53:189-204. Immunol Ser. 1990. PMID: 2100555 Review. No abstract available.
• Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.

  Yu D, Shi D, Scanlon M, Hung MC. Yu D, et al. Cancer Res. 1993 Dec 1;53(23):5784-90. Cancer Res. 1993. PMID: 7902209
• Biological and molecular analysis of p53 cellular-encoded tumor antigen.

  Rotter V, Wolf D. Rotter V, et al. Adv Cancer Res. 1985;43:113-41. doi: 10.1016/s0065-230x(08)60944-6. Adv Cancer Res. 1985. PMID: 3887856 Review. No abstract available.